Profile data is unavailable for this security.
About the company
Zhejiang Hisun Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products. The Company's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The Company is also engaged in the sales of drugs manufactured by other companies. The Company distributes its products in domestic markets and to overseas markets.
- Revenue in CNY (TTM)10.04bn
- Net income in CNY-76.94m
- Incorporated1998
- Employees8.06k
- LocationZhejiang Hisun Pharmaceutical Co LtdNo. 46, Waisha Road, Jiaojiang DistrictTAIZHOU 318000ChinaCHN
- Phone+86 57 185278141
- Fax+86 57 688827887
- Websitehttp://www.hisunpharm.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Animal Husbandry Industry Co., Ltd | 5.47bn | 339.08m | 8.96bn | 4.33k | 26.41 | 1.60 | -- | 1.64 | 0.3321 | 0.3321 | 5.36 | 5.48 | 0.6331 | 4.13 | 4.89 | 1,264,384.00 | 3.33 | 6.23 | 4.71 | 9.01 | 18.95 | 24.29 | 5.26 | 8.69 | 1.86 | -- | 0.2017 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
Shenzhen Chipscreen Biosciences Co Ltd | 547.79m | 103.01m | 9.02bn | 1.06k | 85.81 | 5.34 | -- | 16.47 | 0.2578 | 0.2578 | 1.33 | 4.15 | 0.1761 | 1.66 | 3.97 | 518,248.70 | 2.14 | 1.32 | 2.61 | 1.54 | 86.99 | 93.29 | 12.17 | 6.97 | 2.99 | -- | 0.4037 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
Nanjing Vazyme Biotech Co Ltd | 1.29bn | -15.12m | 9.20bn | 2.70k | -- | 2.28 | -- | 7.16 | -0.0368 | -0.0368 | 3.27 | 10.07 | 0.2191 | 0.9761 | 2.85 | 476,061.10 | -0.286 | 13.16 | -0.3724 | 15.92 | 71.31 | 70.50 | -1.31 | 23.92 | 2.97 | -- | 0.2154 | 32.20 | -63.97 | 49.74 | -111.94 | -- | 48.61 | -- |
Aurisco Pharmaceutical Co Ltd | 1.30bn | 325.73m | 9.33bn | 1.52k | 28.61 | 4.49 | -- | 7.20 | 0.803 | 0.803 | 3.18 | 5.12 | 0.5404 | 1.17 | 4.99 | 852,082.90 | 13.57 | 12.40 | 16.46 | 14.33 | 56.90 | 51.26 | 25.12 | 23.05 | 1.72 | -- | 0.116 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
Zhejiang Hisun Pharmaceutical Co., Ltd. | 10.04bn | -76.94m | 9.34bn | 8.06k | -- | 1.13 | -- | 0.9303 | -0.0823 | -0.0823 | 8.45 | 6.86 | 0.5535 | 3.32 | 4.53 | 1,244,871.00 | -0.5084 | 1.95 | -0.8569 | 3.77 | 38.35 | 40.58 | -0.9187 | 3.43 | 0.6303 | -- | 0.4158 | 26.07 | -13.82 | 0.3618 | -119.05 | -- | -31.58 | -- |
Zhejiang Medicine Co., Ltd. | 8.04bn | 425.74m | 9.61bn | 6.23k | 22.28 | 0.9835 | -- | 1.20 | 0.447 | 0.447 | 8.41 | 10.13 | 0.6329 | 2.91 | 5.57 | 1,290,409.00 | 2.14 | 4.32 | 2.75 | 5.68 | 31.16 | 36.57 | 3.39 | 6.28 | 1.62 | 5.95 | 0.0819 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
Shanghai Runda Medical Technology Co Ltd | 9.04bn | 214.86m | 9.74bn | 3.32k | 43.72 | 2.25 | -- | 1.08 | 0.3719 | 0.3719 | 15.65 | 7.22 | 0.6219 | 4.66 | 1.56 | 2,727,524.00 | 2.55 | 4.78 | 7.04 | 12.86 | 26.02 | 27.13 | 4.10 | 6.36 | 1.06 | 7.84 | 0.5568 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
Jianmin Pharmaceutical Group Co Ltd | 4.17bn | 521.42m | 9.96bn | 2.50k | 19.04 | 4.23 | -- | 2.39 | 3.41 | 3.41 | 27.26 | 15.35 | 1.04 | 5.81 | 4.34 | 1,669,960.00 | 13.09 | 10.87 | 23.66 | 19.11 | 43.70 | 43.04 | 12.56 | 9.32 | 1.26 | -- | 0.1891 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
Data as of May 31 2024. Currency figures normalised to Zhejiang Hisun Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 9.31m | 0.78% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 7.67m | 0.64% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 4.87m | 0.41% |
HSBC Jintrust Fund Management Co. Ltd.as of 31 Dec 2023 | 3.20m | 0.27% |
The Vanguard Group, Inc.as of 30 Apr 2024 | 2.80m | 0.24% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.59m | 0.13% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.47m | 0.12% |
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.31m | 0.11% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 807.50k | 0.07% |
Vanguard Global Advisers LLCas of 30 Apr 2024 | 720.10k | 0.06% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.